Tech Company Financing Transactions
Semarion Funding Round
Semarion closed a $3.8 million funding round on 3/31/2026. Investors included ParkWalk Advisors, Cambridge Capital and Cambridge Enterprise.
Transaction Overview
Company Name
Announced On
3/31/2026
Transaction Type
Venture Equity
Amount
$3,800,000
Round
Undisclosed
Investors
Proceeds Purpose
The new funding will support Semarion in scaling manufacturing of the SemaCyte platform while advancing its commercial expansion.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Cavendish Laboratories JJ Thomson Ave.
Cambridge, CB3 0HE
UK
Cambridge, CB3 0HE
UK
Phone
Undisclosed
Website
Email Address
Overview
Semarion is built on fostering collaboration across disciplines to tackle foundational bottlenecks in drug discovery. We operate at the edge of the physical and life sciences by using microchip industry materials and techniques to transform cell-based research.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Wallace
Chief Executive Officer
Jeroen Verheyen
Chief Technical Officer
Tarun Vemulkar
Browse more venture capital transactions:
Prev: 3/31/2026: WHOOP venture capital transaction
Next: 3/31/2026: Valinor Digital venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs